Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 comparative study of K-877 versus fenofibrate in hyperlipidemia
jRCT2080222569Phase 3
- Sponsor
- Kowa Company, Ltd.
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of pemafibrate in hyperlipidemia and dyslipidemia (2 arms), sponsored by Kowa Company, Ltd.
02
Drugs
pemafibrate
03
Conditions
hyperlipidemiadyslipidemia
Beyond the preview
Go deeper on jRCT2080222569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222569.